Clinical Trial Update: A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles [Phase 3]

View source ↗

Summary

A multicenter Phase 3 non-comparative trial evaluating the contraceptive efficacy, safety, and tolerability of LPRI-424 over 13 cycles has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• LPRI-424

Snippet

Sponsor: Insud Pharma | Conditions: Contraception | Phase 3 | Status: COMPLETED